| English Alias: |
Vildagliptin;Vildagliptin (NVP-LAF 237);(-)-(2S)-1-[[(3-Hydroxytricyclo[3.3.1.1[3,7]]dec-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile;2-Pyrrolidinecarbonitrile, 1-(((3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)amino)acetyl)-, (2S)-;Galvus;Laf 237;Unii-I6B4B2U96p;Vildagliptin (LAF-237);2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-;Vildagliptin (LAF237,Galvus®,Zomelis®);Vildagliptin iMpurity;NVP-LAF 237;2-Pyrrolidinecarbonitrile,1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- (9CI);(-)-(2S)-1-[[(3-Hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile;Xiliarx;Jalra;Equa;LAF237;(2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile;I6B4B2U96P;(2S)-1-{2-[(3-hydroxyadamantan-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile;(2S)-1-[N-(3-Hydroxyadamantan-1-yl)glycyl]pyrrolidine-2-carbonitrile;(S)-1-[2-[(3-Hy;NVP-LAF-237;(S)-1-(2-(((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile;274901-16-5;AKOS015898120;SYOKIDBDQMKNDQ-XWTIBIIYSA-N;DTXSID80881091;VILDAGLIPTIN [MART.];DTXCID201022401;(2S)-1-(((3-Hydroxytricyclo(3.3.1.13,7)dec-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile;Vildagliptina;DB04876;GTPL6310;VILDAGLIPTIN [EMA EPAR];Vildagliptin (JAN/USAN/INN);CHEBI:135285;2-PYRROLIDINECARBONITRILE, 1-(((3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)AMINO)ACETYL)-, (2S)-;Vitagliptin;VILDAGLIPTIN [INN];(2S)-1-{2-[(3-Hydroxyadamant-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile;NVP-LAF237;A10BH02;CCG-267505;VILDAGLIPTIN [WHO-DD];NCGC00386200-01;NS00010516;Vildagliptin [USAN:INN:BAN:JAN];s3033;CS-1465;SCHEMBL16579;Vildagliptin- Bio-X;Zomelis;Vildagliptin [USAN];Q421042;VILDAGLIPTIN [JAN];CHEMBL142703;2S)-1-[[(3-Hydroxytricyclo[3.3.1.13,7]decane-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile;AC-1273;Vidagliptin (see Vildagliptin);1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2S-pyrrolidinecarbonitrile;A10BD08;vildagliptinum;(2S)-1-{[(3-hydroxyadamant-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile;Equa (TN);VILDAGLIPTIN [MI];(2S)-1-(((3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)AMINO)ACETYL)PYRROLIDINE-2-CARBONITRILE;vildagliptine;D07080;EN300-18527744;AB01566863_01;(2S)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile;SW220049-1;Galvus (TN);1ST11066;LAF-237;VILDAGLIPTIN (MART.);(2S)-1-{[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile;(2S)-{((3-Hydroxyadamantan-1-yl)amino)acetyl}pyrrolidine-2-carbonitrile;(-)-(2S)-1-(((3-HYDROXYTRICYCLO(3.3.1.1(SUP(3,7))DEC-1-YL)AMINO)ACETYL)PYRROLIDINE-2-CARBONITRILE;HY-14291;BDBM11695;AM20090695;BV164521;NCGC00386200-02;BRD-A94993966-001-05-1;BRD-A94993966-001-04-4 |
![2-pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2s)-](https://struc.chem960.com/strucimg/275000/eddine31gryaz4s1jiaiowee.png)
![tert-butyl rel-(1R,2S,5S)-2-(aminomethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate](http://www.artkmedchem.cn/content/xtheme/airuitike/images/noimage.jpg)
ARTK-22615
tert-butyl rel-(1R,2S,5S)-2-(aminomethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate
Sign in
My Cart
0